Skip to content

Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review

Mr Price

MRP · A2X Markets · Incorporated in South Africa · Consolidated statements

On this page
Company details
Legal name
Mr Price Group Limited
Incorporated in
South Africa
Listing
MRP on the A2X Markets, active · ISIN ZAE000200457 (observed 2026-10-08)
Sector
Not classified (our classification from the stated principal activity)
Financial year ends
28 March

Overview

Year ended 28 March 2026 · audited financial statements, signed / final · source

  • Revenue

    ZAR 42.7 billion

    42,654 ZAR millions · p13

    +4.2% vs 2025

  • Operating profit / (loss)

    ZAR 6.03 billion

    6,028 ZAR millions · p13

    +4.3% vs 2025

  • Profit / (loss) for the year

    ZAR 3.85 billion

    3,850 ZAR millions · p13

    +1.6% vs 2025

  • Total assets

    ZAR 40.7 billion

    40,687 ZAR millions · p14

    +25.0% vs 2025

  • Total equity

    ZAR 15.3 billion

    15,328 ZAR millions · p14

    +6.3% vs 2025

  • Cash from operations

    ZAR 8.02 billion

    8,015 ZAR millions · p14

    −5.1% vs 2025

Large amounts are rounded for reading (ZAR million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.

Financial statements

Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in ZAR millions unless the row says otherwise; brackets are negative.

† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table

Column sources

  • FY to 28 Mar 2026 — audited financial statements, signed / final; reported for the year · source
  • FY to 29 Mar 2025 — audited financial statements, signed / final; comparative in the FY to 28 Mar 2026 filing · source
  • FY to 30 Mar 2024 — audited financial statements, signed / final; comparative in the FY to 29 Mar 2025 filing · source

Income statement

Income statement, ZAR millions. Columns: FY to 28 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 29 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 30 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 28 Mar 2026Audited financial statementsreported for the yearFY to 29 Mar 2025Audited financial statementscomparative in FY to 28 Mar 2026 filingFY to 30 Mar 2024Audited financial statementscomparative in FY to 29 Mar 2025 filing
Revenue1 42,654 40,933 37,944
Retail sales2 41,146 39,439 36,586
Other revenue excluding interest charged on debtors*3 791 808 740
Interest on debtors4 462 468 457
Finance interest income5 255 218 161
Retail sales and other revenue6 42,399 40,715 37,783
Costs and expenses7 (36,371) (34,935) (32,476)
Cost of sales (24,324) (23,574) (22,144)
Selling expenses8 (8,833) (8,464) (7,665)
Administrative and other operating expenses9 (3,214) (2,897) (2,667)
Profit before finance costs and finance income 6,028 5,780 5,307
Finance interest income 255 218 161
Finance costs (867) (823) (806)
Profit before taxation 5,416 5,175 4,662
Taxation (1,566) (1,386) (1,238)
Net profit for the year 3,850 3,789 3,424
Non-controlling interest10 118 142 144
Currency translation adjustments11 (17) (43) (13)
Fair value adjustments on financial instruments12 97 Not reported in this filing13 (27)
Deferred taxation on financial instruments1415 (26) Not reported in this filing16 7
Cash flow hedging loss17 (230) –18 Not reported in this filing19
Taxation on cash flow hedge loss20 68 –18 Not reported in this filing21
Defined benefit fund actuarial gain2223 19 Not reported in this filing24 (6)
Deferred taxation thereon25 (5) Not reported in this filing26 1
Total comprehensive income for the year27 3,756 3,746 3,386
Equity holders of parent2829 3,638 3,604 3,242
Non-controlling interest30 118 142 144
  1. Printed “-”, read as nil: subtotal_arithmetic: is.total_comprehensive_income.
Notes and alternative reported figures (29)
  1. “Revenue”: mapping to a shared definition is uncertain. Printed 'Revenue' as a total that includes finance interest income (255; 2025: 218), which is printed again below operating profit.
  2. “Retail sales” is an issuer-specific line, not mapped to a shared definition: Component of revenue.
  3. “Other revenue excluding interest charged on debtors*” is an issuer-specific line, not mapped to a shared definition: Component of revenue; includes insurance revenue.
  4. “Interest on debtors” is an issuer-specific line, not mapped to a shared definition: Component of revenue.
  5. “Finance interest income” is an issuer-specific line, not mapped to a shared definition: Component of the printed revenue total; printed again below operating profit.
  6. “Retail sales and other revenue” is an issuer-specific line, not mapped to a shared definition: Revenue less finance interest income, as printed.
  7. “Costs and expenses” is an issuer-specific line, not mapped to a shared definition: Subtotal of cost of sales, selling expenses and administrative and other operating expenses.
  8. “Selling expenses” is an issuer-specific line, not mapped to a shared definition: Component of costs and expenses.
  9. “Administrative and other operating expenses”: mapping to a shared definition is uncertain. Printed as one line 'Administrative and other operating expenses'.
  10. “Non-controlling interest” is an issuer-specific line, not mapped to a shared definition: Attribution of profit.
  11. “Currency translation adjustments” is an issuer-specific line, not mapped to a shared definition: Note 31; OCI, items that will be reclassified.
  12. “Fair value adjustments on financial instruments” is an issuer-specific line, not mapped to a shared definition: Note 18.6; OCI; 2025 printed '-*' (less than R1 million).
  13. Not reported in this filing: Exact amount not reported: the column prints '-*' on the line 'Fair value adjustments on financial instruments' (p13, page image); the statement's footnote defines '-*' as an amount of less than R1 million. It is not read as nil and no amount is entered.
  14. “Deferred taxation on financial instruments” is an issuer-specific line, not mapped to a shared definition: Note 18.6; OCI; 2025 printed '-*'.
  15. Printed under different labels across filings: “Deferred taxation on financial instruments”; “Deferred taxation thereon”.
  16. Not reported in this filing: Exact amount not reported: the column prints '-*' on the line 'Deferred taxation on financial instruments' (p13, page image); the statement's footnote defines '-*' as an amount of less than R1 million. It is not read as nil and no amount is entered.
  17. “Cash flow hedging loss” is an issuer-specific line, not mapped to a shared definition: Note 18.6; OCI; 2025 printed '-'.
  18. Not reported in this filing: Not reported: the FY2025 document's Consolidated Statement of Comprehensive Income (p13, right half) prints OCI lines 'Currency translation adjustments', 'Fair value adjustments on financial instruments', 'Deferred taxation thereon', 'Defined benefit fund actuarial loss', 'Deferred taxation thereon'; there is no 'Cash flow hedging loss' line for 2024. Checked on the page image (p13).
  19. “Taxation on cash flow hedge loss” is an issuer-specific line, not mapped to a shared definition: Note 18.6; OCI; 2025 printed '-'.
  20. Not reported in this filing: Not reported: the FY2025 document's Consolidated Statement of Comprehensive Income (p13, right half) has no 'Taxation on cash flow hedge loss' line for 2024 (OCI lines: currency translation, fair value adjustments on financial instruments and tax, defined benefit actuarial loss and tax). Checked on the page image (p13).
  21. “Defined benefit fund actuarial gain” is an issuer-specific line, not mapped to a shared definition: Note 21.3; OCI, items that will not be reclassified; 2025 printed '-*'.
  22. Printed under different labels across filings: “Defined benefit fund actuarial gain”; “Defined benefit fund actuarial loss”.
  23. Not reported in this filing: Exact amount not reported: the column prints '-*' on the line 'Defined benefit fund actuarial gain' (p13, page image); the statement's footnote defines '-*' as an amount of less than R1 million. It is not read as nil and no amount is entered.
  24. “Deferred taxation thereon” is an issuer-specific line, not mapped to a shared definition: Note 21.3; OCI; 2025 printed '-*'.
  25. Not reported in this filing: Exact amount not reported: the column prints '-*' on the line 'Deferred taxation thereon' (p13, page image); the statement's footnote defines '-*' as an amount of less than R1 million. It is not read as nil and no amount is entered.
  26. “Total comprehensive income for the year”: mapping to a shared definition is uncertain. Label printed over two lines: 'Total comprehensive income for the year attributable to shareholders, net of taxation'; the second printing (after the attribution) is read; both print 3 746 / 3 386.
  27. “Equity holders of parent” is an issuer-specific line, not mapped to a shared definition: Attribution of total comprehensive income.
  28. Printed under different labels across filings: “Equity holders of parent”; “Owners of the parent”.
  29. “Non-controlling interest” is an issuer-specific line, not mapped to a shared definition: Attribution of total comprehensive income.

Balance sheet

Balance sheet, ZAR millions. Columns: FY to 28 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 29 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 30 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 28 Mar 2026Audited financial statementsreported for the yearFY to 29 Mar 2025Audited financial statementscomparative in FY to 28 Mar 2026 filingFY to 30 Mar 2024Audited financial statementscomparative in FY to 29 Mar 2025 filing
Non-current assets 17,265 16,867 16,838
Property, plant and equipment 4,634 4,254 4,072
Right-of-use asset 7,156 7,187 7,237
Intangible assets 4,968 4,985 5,101
Long-term receivables and other investments1 77 77 44
Defined benefit fund asset2 130 101 89
Deferred taxation assets 300 263 295
Current assets 23,422 15,672 12,978
Inventories 8,290 7,894 7,078
Trade and other receivables 3,197 3,134 2,969
Derivative financial instruments 101 15 2
Cell captive structure3 152 163 124
Taxation 9 6 7
Term deposits4 –5 313 –5
Cash and cash equivalents 11,673 4,147 2,798
Total assets 40,687 32,539 29,816
Capital reserves6 468 360 567
Treasury share transactions7 (3,034) (2,674) (2,485)
Retained income 19,145 18,031 16,529
Foreign currency translation reserve8 (301) (284) (241)
Defined benefit fund reserve9 12 (2) (2)
Cash flow hedge reserve10 (91) Not reported in this filing11 Not reported in this filing11
Other non-distributable reserves1213 (1,605) (1,999) (2,005)
Equity attributable to equity holders of parent14 14,594 13,432 12,363
Non-controlling interest 734 988 1,058
Total equity15 15,328 14,420 13,421
Non-current liabilities16 13,550 7,959 8,491
Lease liabilities 6,215 6,355 6,512
Deferred taxation liability 311 324 343
Interest-bearing loans 7,000 –17 38
Post retirement medical benefits18 24 23 22
Non-controlling interest liability1920 –17 1,257 1,576
Current liabilities21 11,809 10,160 7,904
Trade and other payables 6,703 6,424 5,175
Derivative financial instruments 2 16 2
Other financial liability22 243 –23 Not reported in this filing24
Lease liabilities 2,458 2,331 2,126
Taxation 798 647 138
Non-controlling interest liability2520 1,605 742 429
Total liabilities26 25,359 18,119 16,395
Total equity and liabilities27 40,687 32,539 29,816
Reinsurance assets Not reported in this filing28 Not reported in this filing3029 –5
Current portion of interest-bearing loans Not reported in this filing31 Not reported in this filing3229 34
Reinsurance liabilities Not reported in this filing33 Not reported in this filing3429 –23
  1. Printed “-”, read as nil: subtotal_arithmetic: bs.current_assets.
  2. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_liabilities.
  3. Printed “-”, read as nil: subtotal_arithmetic: bs.current_liabilities.
Notes and alternative reported figures (31)
  1. “Long-term receivables and other investments” is an issuer-specific line, not mapped to a shared definition: Note 17; non-current assets.
  2. “Defined benefit fund asset” is an issuer-specific line, not mapped to a shared definition: Note 21; non-current assets.
  3. “Cell captive structure” is an issuer-specific line, not mapped to a shared definition: Note 11; current assets.
  4. “Term deposits” is an issuer-specific line, not mapped to a shared definition: Note 18.9; current assets; 2026 printed '-'.
  5. “Capital reserves” is an issuer-specific line, not mapped to a shared definition: Note 29; equity.
  6. “Treasury share transactions” is an issuer-specific line, not mapped to a shared definition: Note 30; equity (negative).
  7. “Foreign currency translation reserve” is an issuer-specific line, not mapped to a shared definition: Note 31; equity.
  8. “Defined benefit fund reserve” is an issuer-specific line, not mapped to a shared definition: Note 21.3; equity.
  9. “Cash flow hedge reserve” is an issuer-specific line, not mapped to a shared definition: Equity; 2025 printed '-*' (less than R1 million).
  10. Not reported in this filing: Exact amount not reported: the column prints '-*' on the line 'Cash flow hedge reserve' (p14, page image); the statement's footnote defines '-*' as an amount of less than R1 million. It is not read as nil and no amount is entered.
  11. “Other non-distributable reserves” is an issuer-specific line, not mapped to a shared definition: Note 24; equity (non-controlling interest liability reserve).
  12. Printed under different labels across filings: “Other non-distributable reserves”; “Other non-distributable reserves^”.
  13. Printed under different labels across filings: “Equity attributable to equity holders of parent”; “Equity attributable to equity holders of parent^”.
  14. Printed under different labels across filings: “Total equity”; “Total equity^”.
  15. Printed under different labels across filings: “Non-current liabilities”; “Non-current liabilities^”.
  16. “Post retirement medical benefits” is an issuer-specific line, not mapped to a shared definition: Note 21.2; non-current liabilities.
  17. “Non-controlling interest liability” is an issuer-specific line, not mapped to a shared definition: Note 24; 2026 printed '-'.
  18. Printed under different labels across filings: “Non-controlling interest liability”; “Non-controlling interest liability^”.
  19. Printed under different labels across filings: “Current liabilities”; “Current liabilities^”.
  20. “Other financial liability” is an issuer-specific line, not mapped to a shared definition: Note 18.9; current liabilities.
  21. Not reported in this filing: Not reported: the FY2025 document's Consolidated Statement of Financial Position (p14) current liabilities are 'Trade and other payables', 'Current portion of interest-bearing loans', 'Derivative financial instruments', 'Lease liabilities', 'Taxation', 'Reinsurance liabilities', 'Non-controlling interest liability'; there is no 'Other financial liability' line for 2024. Checked on the page image (p14).
  22. “Non-controlling interest liability” is an issuer-specific line, not mapped to a shared definition: Note 24; current liabilities.
  23. Printed under different labels across filings: “Total liabilities”; “Total liabilities^”.
  24. Printed under different labels across filings: “Total equity and liabilities”; “Total equity and liabilities^”.
  25. Not reported in this filing: Not reported: the FY2026 document's Consolidated Statement of Financial Position (p14) has no 'Reinsurance assets' line for 2026; current assets are inventories, trade and other receivables, derivative financial instruments, cell captive structure, taxation, term deposits, cash and cash equivalents. Checked on the page image (p14).
  26. Audited financial statements dated 2025-06-18 presents this line for this year: - (p14). Not shown in this column, which follows one filing's presentation.
  27. Not reported in this filing: Not reported: the FY2026 document's Consolidated Statement of Financial Position (p14) has no 'Reinsurance assets' line for 2025; current assets are inventories, trade and other receivables, derivative financial instruments, cell captive structure, taxation, term deposits, cash and cash equivalents. Checked on the page image (p14).
  28. Not reported in this filing: Not reported: the FY2026 document's Consolidated Statement of Financial Position (p14) has no 'Current portion of interest-bearing loans' line for 2026; interest-bearing loans appear only under non-current liabilities ('Interest-bearing loans' 7 000 / -). Checked on the page image (p14).
  29. Not reported in this filing: Not reported: the FY2026 document's Consolidated Statement of Financial Position (p14) has no 'Current portion of interest-bearing loans' line for 2025; interest-bearing loans appear only under non-current liabilities ('Interest-bearing loans' 7 000 / -). Checked on the page image (p14).
  30. Not reported in this filing: Not reported: the FY2026 document's Consolidated Statement of Financial Position (p14) has no 'Reinsurance liabilities' line for 2026. Checked on the page image (p14).
  31. Not reported in this filing: Not reported: the FY2026 document's Consolidated Statement of Financial Position (p14) has no 'Reinsurance liabilities' line for 2025. Checked on the page image (p14).

Cash flow

Cash flow, ZAR millions. Columns: FY to 28 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 29 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 30 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 28 Mar 2026Audited financial statementsreported for the yearFY to 29 Mar 2025Audited financial statementscomparative in FY to 28 Mar 2026 filingFY to 30 Mar 2024Audited financial statementscomparative in FY to 29 Mar 2025 filing
Operating profit before working capital changes1 9,007 8,577 7,885
Working capital changes2 (159) 87 122
Cash generated from operations 8,848 8,664 8,007
Interest on trade receivables3 462 468 459
Finance costs paid4 (60) (69) (95)
Finance income received 255 216 161
Taxation paid (1,490) (837) (1,386)
Net cash inflows from operating activities 8,015 8,442 7,146
Receipts in respect of long-term receivables5 8 8 3
Drawdown of deposits6 –7 (344) –7
Increase in deposits8 313 31 –7
- Addition (84) (47) (69)
- Replacement9 (199) (211) (247)
- Addition10 (835) (586) (668)
Proceeds on disposal of PPE 5 15 3
Proceeds from insurance relating to PPE11 2 6 2
Proceeds from disposal of investment12 3 –7 Not reported in this filing13
Net cash outflows from investing activities (787) (1,128) (976)
Receipts relating to sale of shares by staff share trusts14 2 190 27
Treasury share purchased15 (113) (124) (22)
Payment relating to share hedging costs and instruments16 (167) (266) (111)
Repayment of interest-bearing loans and settlement of short-term loans (1,300) (18) Not reported in this filing17
Advances of interest bearing loans and short-term loans 8,300 –18 Not reported in this filing19
Payment relating to acquisition of non-controlling interest20 (770) (453) –18
Repayment of capital portion of lease liabilities (2,487) (2,278) (2,089)
Repayment of interest portion of lease liabilities (786) (755) (715)
Repayment of interest and capital portion of instalment sale agreements212223 –18 (52) –18
Dividends paid (2,404) (2,178) (1,911)
Net cash inflows from financing activities2425 275 (5,934) (4,813)
Total cash movement for the year 7,503 1,380 1,357
Cash and cash equivalents at beginning of the year 4,147 2,798 1,442
Exchange gain/ (losses)26 23 (31) (1)
Cash and cash equivalents at end of the year 11,673 4,147 2,798
(Decrease)/increase to interest-bearing loans27 Not reported in this filing28 Not reported in this filing3029 8
  1. Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_investing.
  2. Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (28)
  1. “Operating profit before working capital changes” is an issuer-specific line, not mapped to a shared definition: Note 13.1; operating activities.
  2. “Working capital changes” is an issuer-specific line, not mapped to a shared definition: Note 13.2; operating activities.
  3. “Interest on trade receivables” is an issuer-specific line, not mapped to a shared definition: Operating activities.
  4. “Finance costs paid”: mapping to a shared definition is uncertain. Printed 'Finance costs paid' in operating activities; lease interest is printed separately in financing activities.
  5. “Receipts in respect of long-term receivables” is an issuer-specific line, not mapped to a shared definition: Note 13.4; investing activities.
  6. “Drawdown of deposits” is an issuer-specific line, not mapped to a shared definition: Investing activities; 2026 printed '-'.
  7. “Increase in deposits” is an issuer-specific line, not mapped to a shared definition: Investing activities, as printed.
  8. “- Replacement” is an issuer-specific line, not mapped to a shared definition: Note 14; investing activities.
  9. “- Addition” is an issuer-specific line, not mapped to a shared definition: Note 14; investing activities.
  10. “Proceeds from insurance relating to PPE” is an issuer-specific line, not mapped to a shared definition: Investing activities.
  11. “Proceeds from disposal of investment” is an issuer-specific line, not mapped to a shared definition: Investing activities; 2025 printed '-'.
  12. Not reported in this filing: Not reported: the FY2025 document's Consolidated Statement of Cash Flows (p15) investing lines end with 'Proceeds on disposal of PPE' and 'Proceeds from insurance relating to PPE'; there is no 'Proceeds from disposal of investment' line for 2024. Checked on the page image (p15).
  13. “Receipts relating to sale of shares by staff share trusts” is an issuer-specific line, not mapped to a shared definition: Note 30; financing activities.
  14. “Treasury share purchased” is an issuer-specific line, not mapped to a shared definition: Note 30; financing activities.
  15. “Payment relating to share hedging costs and instruments” is an issuer-specific line, not mapped to a shared definition: Financing activities.
  16. Not reported in this filing: Not reported separately: the FY2025 document's cash-flow statement (p15) prints a single net line '(Decrease)/increase to interest-bearing loans' (2024: 8), already transcribed as net_change_interest_bearing_loans; no separate repayment line. Checked on the page image (p15).
  17. Not reported in this filing: Not reported separately: the FY2025 document's cash-flow statement (p15) prints a single net line '(Decrease)/increase to interest-bearing loans' (2024: 8), already transcribed as net_change_interest_bearing_loans; no separate advances line. Checked on the page image (p15).
  18. “Payment relating to acquisition of non-controlling interest” is an issuer-specific line, not mapped to a shared definition: Note 24; financing activities.
  19. “Repayment of interest and capital portion of instalment sale agreements” is an issuer-specific line, not mapped to a shared definition: Note 20; financing; 2026 printed '-'.
  20. “Repayment of interest and capital portion of instalment sale agreements”: mapping to a shared definition is uncertain. Label printed over two lines ('... installment sale agreements'); the amounts sit between the two lines.
  21. Printed under different labels across filings: “Repayment of interest and capital portion of installment sale”; “Repayment of interest and capital portion of instalment sale agreements”.
  22. “Net cash inflows from financing activities”: mapping to a shared definition is uncertain. Printed 'Net cash inflows from financing activities' for both years; the 2025 figure is an outflow ((5 934)).
  23. Printed under different labels across filings: “Net cash inflows from financing activities”; “Net cash outflows from financing activities”.
  24. Printed under different labels across filings: “Exchange gain/ (losses)”; “Exchange losses”.
  25. “(Decrease)/increase to interest-bearing loans” is an issuer-specific line, not mapped to a shared definition: Financing activities; printed as one net line in 2025 (the 2026 statement prints repayments and advances separately).
  26. Not reported in this filing: Not reported: the FY2026 document's cash-flow statement (p14, right half) prints gross lines 'Repayment of interest-bearing loans and settlement of short-term loans' and 'Advances of interest bearing loans and short-term loans' instead of the net '(Decrease)/increase to interest-bearing loans' line; no net line for 2026. Checked on the page image (p14).
  27. Audited financial statements dated 2025-06-18 presents this line for this year: (18) (p15). Not shown in this column, which follows one filing's presentation.
  28. Not reported in this filing: Not reported: the FY2026 document's cash-flow statement (p14, right half) prints gross lines 'Repayment of interest-bearing loans and settlement of short-term loans' and 'Advances of interest bearing loans and short-term loans' instead of the net '(Decrease)/increase to interest-bearing loans' line; no net line for 2025. Checked on the page image (p14).

Per share and shares

Per share and shares. Columns: FY to 28 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 29 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 30 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 28 Mar 2026Audited financial statementsreported for the yearFY to 29 Mar 2025Audited financial statementscomparative in FY to 28 Mar 2026 filingFY to 30 Mar 2024Audited financial statementscomparative in FY to 29 Mar 2025 filing
Earnings / (loss) per share (per share)51 14.4952 14.1633 12.7624
Profit / (loss) attributable to shareholders (ZAR millions)6 3,732 3,647 3,280
  1. Printed as 1 449.5 cents; value converted to ZAR at 100 cents = 1 ZAR.
  2. Printed as 1 416.3 cents; value converted to ZAR at 100 cents = 1 ZAR.
  3. Printed as 1 276.2 cents; value converted to ZAR at 100 cents = 1 ZAR.
Notes and alternative reported figures (3)
  1. “Basic”: mapping to a shared definition is uncertain. Basic EPS (cents); diluted basic EPS is printed separately and differs (native eps_diluted).
  2. Earnings / (loss) per share: printed as “Basic”.
  3. Profit / (loss) attributable to shareholders: printed as “Equity holders of parent”.

Segments

Segment data not yet collected for this company in the pilot.

Dividends

Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.

Dividend events, the issuer's wording, and amounts as printed
Year endedEventWording as printedAmountUnitSource
28 Mar 2026 Dividends paid (cash flow statement) Dividends paid (2,404) ZAR millions Audited financial statements, p14
29 Mar 2025 Dividends paid (cash flow statement) Dividends paid (2,178) ZAR millions Audited financial statements, p14
30 Mar 2024 Dividends paid (cash flow statement) Dividends paid (1,911) ZAR millions Audited financial statements, p15

Sources

Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.

  • Mr Price Group Annual Financial Statements 2026, 30 March 2025 - 28 March 2026 (Annual Integrated Report 2026, chapter 08)

    Year ended 28 March 2026 · Audited financial statements · signed / final

    Audit: Deloitte & Touche, unmodified opinion · signed

    Auditor's sign-off: Deloitte & Touche, Registered Auditor, per Camilla Howard-Browne CA(SA) RA, Partner

    Final status: Independent auditor's report of Deloitte & Touche to the shareholders of Mr Price Group Limited (opinion PDF p9) closes on PDF p11 with a DocuSigned 'Deloitte & Touche' signature above 'Deloitte & Touche, Registered Auditor, IRBA: 902276, Per: Camilla Howard-Browne (CA) SA; RA, Partner, 19 June 2026' (page image). Approval of the annual financial statements (PDF p3): approved by the board on 19 June 2026 and signed on its behalf by NG Payne (Chairman) and MM Blair (CEO), handwritten signatures visible (page image).

    Document date
    19 Jun 2026
    Auditor's report
    19 Jun 2026
    Board approval
    19 Jun 2026
    Retrieved by us
    8 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 28 Mar 2026, FY to 29 Mar 2025
    Basis
    consolidated statements · ZAR millions (printed “R’m”)
    • Basic EPS 1 449.5 cents (2025: 1 416.3) and diluted basic EPS 1 407.5 cents (2025: 1 371.8) are printed separately (p13); basic mapped to eps_basic_diluted as ambiguous, diluted to a native per-share concept; headline EPS natives. Per-share figures are stored in rand with the printed figure and unit kept (minor_unit).
    • No other-comprehensive-income total is printed; its components are transcribed within total comprehensive income, and comparative cells printed '-*' ('Less than R1 million') are not read (p13). Issued capital prints '-*' in both years (p14) and is not transcribed; equity attributable to equity holders of parent adds up without it. The 2025 cash flow hedge reserve prints '-*' and only the 2026 figure is read. Finance income received, finance costs paid and taxation paid are within operating activities; lease interest within financing activities (p14).
    • The income statement prints 'Revenue' (42 654; 2025: 40 933) as retail sales, other revenue, interest on debtors and finance interest income; 'Retail sales and other revenue' (42 399; 2025: 40 715) excludes finance interest income, which is printed again below 'Profit before finance costs and finance income' (p13). Revenue is recorded as printed and mapped as ambiguous. Costs and expenses, finance costs and taxation are printed as positive amounts and deducted; stored as deductions.
    • 52-week retail calendar: 30 March 2025 to 28 March 2026 (2025: 31 March 2024 to 29 March 2025) (report of the directors, p3). Company-only lines (consolidated entities, amounts owing by/to consolidated entities, dividend income, prepaid investment in Cambrose, purchase of additional shares in Studio 88, grants to and proceeds from share trusts) print '-' in the Group columns and are not transcribed.
    Technical details
    File
    53 pages, with a text layer
    SHA-256
    c09ea4dd8064cf5632a074943e2307a92034c6579d10e780bbaaeef6858d5dca
    Entity as printed
    Mr Price Group Limited and its subsidiaries (the Group and the Company) (auditor's report, PDF p9)
    Issuer copy
    retrieved 2026-10-08T18:46:43Z
  • Mr Price Group Annual Financial Statements 2025, 31 March 2024 - 29 March 2025 (Annual Integrated Report 2025)

    Year ended 29 March 2025 · Audited financial statements · signed / final

    Audit: Deloitte & Touche, unmodified opinion · signed

    Auditor's sign-off: Deloitte & Touche, Registered Auditor, per Camilla Howard-Browne CA(SA) RA, Partner

    Final status: Independent auditor's report of Deloitte & Touche to the shareholders of Mr Price Group Limited (opinion PDF p9) closes on PDF p11 with a DocuSigned 'Deloitte & Touche' signature above 'Deloitte & Touche, Registered Auditor, IRBA: 902276, Per: Camilla Howard-Browne (CA) SA; RA, Partner, 18 June 2025' (page image). Approval of the annual financial statements (PDF p3): approved by the board on 18 June 2025 and signed on its behalf by NG Payne (Chairman) and MM Blair (CEO), handwritten signatures visible (page image).

    Document date
    18 Jun 2025
    Auditor's report
    18 Jun 2025
    Board approval
    18 Jun 2025
    Retrieved by us
    8 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 30 Mar 2024
    Basis
    consolidated statements · ZAR millions (printed “R’m”)
    • Investing activities print 'Drawdown of deposits (344)' and 'Increase in deposits 31' for 2025 (p15): the signs read opposite to the labels (term deposits rose to 313 in the statement of financial position). Kept as printed; the investing subtotal adds up with the printed figures.
    • Basic EPS 1 416.3 cents (2024: 1 276.2) and diluted basic EPS 1 371.8 cents (2024: 1 242.9) are printed separately (p13); basic mapped to eps_basic_diluted as ambiguous, diluted to a native per-share concept; headline EPS natives. Per-share figures are stored in rand with the printed figure and unit kept (minor_unit).
    • No other-comprehensive-income total is printed; its components are transcribed within total comprehensive income, and 2025 cells printed '-*' ('Less than R1 million') are not read (p13). Issued capital prints '-*' in both years and the cash flow hedge reserve '-*' in both years (p14); neither is transcribed and equity attributable to equity holders of parent adds up without them. Finance income received, finance costs paid and taxation paid are within operating activities; lease interest within financing activities (p15).
    • The income statement prints 'Revenue' (40 933; 2024: 37 944) as retail sales, other revenue, interest on debtors and finance interest income; 'Retail sales and other revenue' (40 715; 2024: 37 783) excludes finance interest income, which is printed again below 'Profit before finance costs and finance income' (p13). Revenue is recorded as printed and mapped as ambiguous. Costs and expenses, finance costs and taxation are printed as positive amounts and deducted; stored as deductions.
    • The Group statement of financial position prints 2024 and 2023 as 'Restated^': 'The comparative information has been restated due to a prior period error. Refer to note 2 ... The restatement had no impact on earnings per share.' (p14). Lines marked '^' (other non-distributable reserves, equity attributable to equity holders of parent, total equity, non-current and current liabilities, non-controlling interest liability, total liabilities, total equity and liabilities) carry the restated mark on the 2024 value.
    • 52-week retail calendar: 31 March 2024 to 29 March 2025 (2024: 2 April 2023 to 30 March 2024) (report of the directors, p3). Company-only lines (consolidated entities, amounts owing by/to consolidated entities, dividend income, purchase of additional shares in Studio 88, grants to staff share trusts) print '-' in the Group columns and are not transcribed.
    Technical details
    File
    55 pages, with a text layer
    SHA-256
    2b5fdcb215043f8439cc46fca6765e59dff3af8c73e346f4e9358cb0dfdf3c45
    Entity as printed
    Mr Price Group Limited and its subsidiaries (the Group and the Company) (auditor's report, PDF p9)
    Issuer copy
    retrieved 2026-10-08T18:46:39Z

Data notes

No figure-level notes beyond those in the tables.

Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.

Download

Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.

South Africa country page · Company methodology and coverage